Literature DB >> 6830505

Hemolytic complement activity in aqueous humor.

B J Mondino, H Rao.   

Abstract

Hemolytic C1, C4, C3, and C5 and IgG levels were measured in aqueous humor obtained at surgery from human eyes without inflammation or previous surgery (group 1), eyes with previous surgery (group 2), and eyes with anterior uveitis (group 3). Serum hemolytic complement and IgG levels were also compared with aqueous humor levels. Aqueous humor from eyes in group 1 contained functional C1, C4, C3, and C5, but there was relatively little complement in normal aqueous humor when compared with serum. The mean values of all complement components and IgG in aqueous humor increased from groups 1 to 3; aqueous-serum ratios for each complement component and IgG also increased from groups 1 to 3. Eyes in group 3 had the highest complement and IgG levels and in some cases these values approached those found in serum.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6830505     DOI: 10.1001/archopht.1983.01040010465028

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  5 in total

1.  Complement regulatory activity of normal human intraocular fluid is mediated by MCP, DAF, and CD59.

Authors:  J H Sohn; H J Kaplan; H J Suk; P S Bora; N S Bora
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-12       Impact factor: 4.799

Review 2.  Immunological concepts and the eye: a review of the classical and ocular arthus reactions.

Authors:  L D Ormerod
Journal:  Doc Ophthalmol       Date:  1986       Impact factor: 2.379

3.  Immunology of the eye--1983.

Authors:  B J Mondino
Journal:  Surv Immunol Res       Date:  1984

4.  An antimicrobial effect associated with rabbit primary aqueous humour.

Authors:  J P Diamond; J P Leeming; A D Smart; P Duffus; A J Hedges; D L Easty
Journal:  Br J Ophthalmol       Date:  1994-02       Impact factor: 4.638

Review 5.  The role of complement in ocular pathology.

Authors:  Nalini S Bora; Purushottam Jha; Puran S Bora
Journal:  Semin Immunopathol       Date:  2008-02-26       Impact factor: 9.623

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.